Evidence map›Paper›PMID 19965957›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2010

Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens.

Souk Phonethepswath, Dean Franklin, Dorothea K Torous, Steven M Bryce, Jeffrey C Bemis, Sarojini Raja, Svetlana Avlasevich, Pamela Weller, Ollivier Hyrien, James Palis and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies.Toxicological sciences : an official journal of the Society of Toxicology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Souk PhonethepswathLitron Laboratories, Rochester, New York 14623, USA.
Dean Franklin
Dorothea K Torous
Steven M Bryce
Jeffrey C Bemis
Sarojini Raja
Svetlana Avlasevich
Pamela Weller
Ollivier Hyrien
James Palis
James T Macgregor
Stephen D Dertinger
University of Rochester Medical Center · USLitron Laboratories (United States) · USDermatology Consulting Services · US

Funding

Versatile Mutation Assay Based on the Pig-A LocusR44ES015940 · NIEHS · LITRON LABORATORIES, LTD. · PI DERTINGER, STEPHEN D · 2008 to 2009
$768k
NIEHS NIH HHS 1R44ES015940
6 · The paper itself

Abstract

An in vivo mutation assay has been developed based on flow cytometric enumeration of glycosylphosphatidylinositol (GPI) anchor-deficient rat erythrocytes. With this method, blood is incubated with anti-CD59-PE and SYTO 13 dye, and flow cytometry is used to score the frequency of CD59-negative erythrocytes. The experiments described herein were designed to define the kinetics of mutant erythrocyte appearance and disappearance from peripheral blood to support appropriate treatment and sampling designs for the assay. Wistar Han rats were treated with one of five prototypical mutagens: N-ethyl-N-nitrosourea (ENU); 7,12-dimethyl-1,2-benz[a]anthracene (DMBA); 4-nitroquinoline-1-oxide; benzo[a]pyrene; and N-methyl-N-nitrosourea. ENU and DMBA were also evaluated in Sprague Dawley rats. Animals were treated on three consecutive days (days 1-3) via oral gavage, and blood specimens were obtained on days -1, 4, 15, 30, 45, and 90 (and day 180 for ENU). A second endpoint of genotoxicity, the frequency of peripheral blood micronucleated reticulocytes, was measured on day 4. Each chemical induced micronuclei and the GPI anchor-deficient phenotype. Increased mutant cell frequencies were evident at day 15. Mutant reticulocyte frequencies remained relatively stable for some chemicals, but others peaked and then dropped significantly. The differences in kinetics observed are presumably related to the degree to which mutation occurs in hematopoietic stem cells versus more committed cells with limited self-renewal capacity. Collectively, the results suggest that enumerating GPI anchor-deficient erythrocytes is an efficient means of evaluating the in vivo mutagenic potential of chemicals. The kinetics and ease of scoring this blood-based endpoint suggest that integration into routine toxicology studies will be feasible.

Indexed as

4-Nitroquinoline-1-oxide9,10-Dimethyl-1,2-benzanthraceneAnimalsBenzo(a)pyreneErythrocytesEthylnitrosoureaMembrane ProteinsMethylnitrosoureaMutagenicity TestsMutagensMutationRatsRats, Sprague-DawleyRats, Wistar4-Nitroquinoline-1-oxide9,10-Dimethyl-1,2-benzanthraceneBenzo(a)pyreneEthylnitrosoureaMembrane ProteinsMethylnitrosoureaMutagensphosphatidylinositol glycan-class A protein

Identifiers

PMID19965957
PMCPMC2902916
OpenAlexW2119348556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.